Increasing rate of atrial fibrillation from 2003 to 2011 in patients with ischaemic stroke: Results from 55 551 patients in a nationwide registry

European Journal of Neurology

Volumn 22, Issue 5, 2015, Pages 839-844

  Jespersen, S F ^a   Christensen, L M ^a   Christensen, A ^a   Christensen, H ^a  

^a BISPEBJERG HOSPITAL   (Denmark)

Author keywords

Atrial fibrillation; Frequency; Ischaemic stroke; Oral anticoagulation therapy; Secondary stroke prevention; Stroke registry

Indexed keywords

ANTIVITAMIN K; ANTICOAGULANT AGENT;

AGED; ANTICOAGULANT THERAPY; ARTICLE; BRAIN ISCHEMIA; FEMALE; FREQUENCY ANALYSIS; HEART ATRIUM FIBRILLATION; HUMAN; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; TREATMENT OUTCOME; ADULT; ATRIAL FIBRILLATION; COMORBIDITY; DENMARK; MIDDLE AGED; REGISTER; STATISTICS AND NUMERICAL DATA; STROKE; TRENDS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ATRIAL FIBRILLATION; BRAIN ISCHEMIA; COMORBIDITY; DENMARK; FEMALE; HUMANS; MALE; MIDDLE AGED; REGISTRIES; STROKE;

EID: 84926408104     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/ene.12671     Document Type: Article

References (29)

1. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991; 22: 983-988.
2. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study. Arch Intern Med 1987; 147: 1561-1564.
3. Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 2007; 146: 857-867.
4. Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009; 361: 1139-1151.
5. Patel MR, Mahaffey KW, Garg J, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 2011; 365: 883-891.
6. Granger CB, Alexander JH, McMurray JJ, et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2011; 365: 981-992.
7. Friberg L, Hammar N, Ringh M, Pettersson H, Rosenqvist M. Stroke prophylaxis in atrial fibrillation: who gets it and who does not? Report from the Stockholm Cohort study on Atrial Fibrillation (SCAF-study). Eur Heart J 2006; 27: 1954-1964.
8. McCormick D, Gurwitz JH, Goldberg RJ, et al. Prevalence and quality of warfarin use for patients with atrial fibrillation in the long-term care setting. Arch Intern Med 2001; 161: 2458-2463.
9. Adhiyaman V, Kamalakannan D, Oke A, Shah IU, White AD. Underutilization of antithrombotic therapy in atrial fibrillation. J R Soc Med 2000; 93: 138-140.
10. Palm F, Kleemann T, Dos Santos M, et al. Stroke due to atrial fibrillation in a population-based stroke registry (Ludwigshafen Stroke Study) CHADS(2), CHA(2)DS(2)-VASc score, underuse of oral anticoagulation, and implications for preventive measures. Eur J Neurol 2013; 20: 117-123.
11. Palm F, Kraus M, Safer A, Wolf J, Becher H, Grau AJ. Management of oral anticoagulation after cardioembolic stroke and stroke survival data from a population based stroke registry (LuSSt). BMC Neurol 2014; 14: 199.
12. Kannel WB, Wolf PA, Benjamin EJ, Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol 1998; 82: 2N-9N.
13. Heeringa J, van der Kuip DA, Hofman A, et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J 2006; 27: 949-953.
14. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro heart survey on atrial fibrillation. Chest 2010; 137: 263-272.
15. Homepage of the Danish Stroke Registry. http://www.nip.dk (accessed 19/04/2012).
16. The Danish Stroke Registry's annual report 2011. http://www.sundhed.dk/content/cms/69/4669_apopleksi-aarsrapport2011v1124042012.pdf (accessed 25/02/2012).
17. Wildenschild C, Mehnert F, Thomsen RW, et al. Registration of acute stroke: validity in the Danish Stroke Registry and the Danish National Registry of Patients. Clin Epidemiol 2013; 6: 27-36.
18. Jespersen SF, Christensen LM, Christensen A, Christensen H. Use of oral anticoagulation therapy in atrial fibrillation after stroke: results from a nationwide registry. Thrombosis 2013; 2013: 7.
19. Jespersen SF, Christensen LM, Christensen A, Christensen H. Use of oral anticoagulation therapy in atrial fibrillation after stroke: results from a nationwide registry. Thrombosis 2013; 2013: 601450.
20. Saposnik G, Gladstone D, Raptis R, Zhou L, Hart RG. Atrial fibrillation in ischemic stroke: predicting response to thrombolysis and clinical outcomes. Stroke 2013; 44: 99-104.
21. Glader EL, Stegmayr B, Norrving B, et al. Large variations in the use of oral anticoagulants in stroke patients with atrial fibrillation: a Swedish national perspective. J Intern Med 2004; 255: 22-32.
22. Marini C, De Santis F, Sacco S, et al. Contribution of atrial fibrillation to incidence and outcome of ischemic stroke: results from a population-based study. Stroke 2005; 36: 1115-1119.
23. Sandercock P, Bamford J, Dennis M, et al. Atrial fibrillation and stroke: prevalence in different types of stroke and influence on early and long term prognosis (Oxfordshire Community Stroke Project). BMJ 1992; 305: 1460-1465.
24. Lovelock CE, Molyneux AJ, Rothwell PM. Change in incidence and aetiology of intracerebral haemorrhage in Oxfordshire, UK, between 1981 and 2006: a population-based study. Lancet Neurol 2007; 6: 487-493.
25. Camm AJ, Lip GY, De Caterina R, et al. The 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation - developed with the special contribution of the European Heart Rhythm Association. Europace 2012; 14: 1385-1413.
26. Palm F, Urbanek C, Rose S, et al. Stroke incidence and survival in Ludwigshafen am Rhein, Germany: the Ludwigshafen Stroke Study (LuSSt). Stroke 2010; 41: 1865-1870.
27. Danish Stroke Society. http://www.dsfa.dk/wp-content/uploads/REFERENCEPROGRAMFINAL20131.pdf (accessed 26/01/2014).
28. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis 2008; 25: 457-507.
29. Khan M, Miller DJ. Detection of paroxysmal atrial fibrillation in stroke/TIA patients. Stroke Res Treat 2013; 2013: 840265.